Director Business Development and Managing Director Cerba Path

Cyril joined Cerba HealthCare in 2000. 

 

He has more than 20 years of experience in the clinical pathology market. 

He previously worked at Laboratoire Lévy.

Cyril holds a degree in Biology and a degree in Sales & Marketing from ESTBA.

 

Director of Internal Audit and Group DPO

Merryl Durrenbach joined Cerba HealthCare in 2020 as Director of Internal Audit and Group DPO.


Before joining the Group, Merryl spent over 10 years managing Internal Audit functions in internationally listed groups (Vesuvius Plc, SThree Plc).
She holds a Master's degree from ISG and completed an Executive Program at INSEAD. Merryl also holds the CISA.

Director of Partnerships and International Development

Jean-Philippe joined Cerba HealthCare in 2014.

 

He has 20 years experience in M&A operations and capital partnerships in the healthcare market. He previously served as Development manager at Générale de Santé Group and Development director for a network of 100 laboratories.

 

Jean-Philippe holds a master in Finance and a master in Financial techniques. He also holds a Bachelor degree in healthcare business management from HEC.

Deputy Managing Director Cerballiance

Charles joined Cerba HealthCare in 2015.

 

Previoulsy, he managed the Novescia Loire group of clinical pathology laboratories.

Charles holds a PhD in Medicine, a Post-Graduate Degree in clinical pathology and a MBA from EM Lyon.

Managing Director Cerballiance

Laurent joined Cerba HealthCare in 2015.

 

Previously, he managed a group of clinical pathology laboratories in Occitanie. Laurent holds a PhD in pharmacology, a Post-Graduate Degree in clinical pathology, a degree in Medically Assisted Procreation and a MBA from EM Lyon.

Managing Director Ketterthill

Stéphane joined Ketterthill in 2008. 

 

He has more than 20 years of experience in clinical pathology. 

He previously served as Chief of Haematology Department at Military Hospital Legouest, Metz. 

Stéphane holds a Doctor in Pharmacy and was awarded a MBA from EM Lyon. 

Executive Chair of Cerba Research

Dr Nuala Murphy was appointed to the board of Cerba HealthCare in 2023, in addition to assuming the chair of the ESG committee and executive chair of Cerba Research. 

 

With a background in drug development, Nuala is a strategic advisor to private equity, having held leadership & board roles in the pharmaceutical sector, most recently as President of Drug development and Commercialization at ICON Plc. 

 

Nuala graduated from Trinity College Dublin, was awarded a PhD from the School of Medicine at the University of Leeds, a post-doctorate in neuroscience from the Collège de France, Paris, a diploma in ESG from the Corporate Governance Institute and was certified in corporate governance at INSEAD.

Managing Director Cerba

Aurélie joined Cerba HealthCare in 2015. 

 

Prior to becoming CEO of Cerba in 2022, Aurélie was President of Cerballiance South Paris Region, and then Head of Asia Pacific and Global Lead of Laboratory Partnership for Cerba Research.

Aurélie is a Doctor of Pharmacy and graduated from EM Lyon business school. 

Managing Director

Philippe joined Cerba HealthCare in 2011.

 

He previously served as General Manager for the south of France region at Générale de Santé Group.

Philippe received a degree from the University Paris X and an Executive Management degree from HEC.

Chairman

Paul joined Cerba HealthCare in 2023.

 

Paul spent 30 years in management positions at Procter & Gamble, Allergan (President) and Ferring Inc (CEO).

 

He is currently a member of the board of directors of several companies around the world (LEO Pharma, HTL, Hallura) while advising private equity funds and acting as Chairman of the Board of Cerba HealthCare.

 

Paul has also been interim CEO of Cerba HealthCare since 14 March 2025.

 

Paul graduated from Institut Supérieur de Commerce business school, and INSEAD in corporate governance.

Subscribe to